CASI PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
CASI PHARMACEUTICALS, INC. had Operating Lease Right-of-Use Assets of $1.40 million as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-04-26
- 2022-12-31: Operating Lease, Right-of-Use Asset $1.40M.
- 2022-09-30: Operating Lease, Right-of-Use Asset $7.67M.
- 2022-06-30: Operating Lease, Right-of-Use Asset $8.46M.
- 2022-03-31: Operating Lease, Right-of-Use Asset $8.81M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2022-12-31 | $1.40M 20-F · filed 2023-04-26 |
| 2022-09-30 | $7.67M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $8.46M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $8.81M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $9.11M 20-F · filed 2023-04-26 |
| 2021-09-30 | $9.50M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $9.80M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $8.32M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $8.70M 10-K · filed 2022-03-28 |
| 2020-09-30 | $9.02M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $7.96M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $8.26M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $8.71M 10-K · filed 2021-03-30 |
| 2019-09-30 | $2.36M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.72M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.03M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |